Back

Plant Scaffolds Support Motor Recovery and Regeneration in Rat Spinal Cord Injury

Modulevsky, D. J.; Cuerrier, C. M.; Leblanc-Latour, M.; Hickey, R. J.; Obhi, R.-J. K.; Shore, I.; Galuta, A.; Walker, K. L. A.; Tsai, E. C.; Pelling, A. E.

2020-10-22 bioengineering
10.1101/2020.10.21.347807 bioRxiv
Show abstract

As of yet, no standard of care incorporates biomaterials to treat traumatic spinal cord injury (SCI). However, intense development of biomaterials for treating SCI has focused on fabricating microscale channels to support the regrowth of axons while minimizing scar formation. We previously demonstrated that plant tissues could be decellularized and processed to form sterile, biocompatible and implantable biomaterials that support cell infiltration and vascularization in vivo. Vascularized plant tissues contain continuous microscale channels with geometries relevant for supporting neural regeneration. We hypothesized that decellularized vascular bundles would support neural regeneration and motor recovery in SCI. Sprague Dawley rats received a complete T8-T9 spinal cord transection and were implanted with acellular plant-derived scaffolds and allowed to recover over 28 weeks. Animals that received the scaffolds alone, with no other therapeutic compounds, demonstrated a significant and stable partial improvement in motor function compared to control animals as early as week 4 post-injury. Hind-limb motor function did not deteriorate over the remaining 28 weeks. Histological analysis revealed minimal astrocyte scarring at the spinal cord - scaffold interface, aligned axonal projection through the scaffolds, populations of serotonergic neurons and Schwann cells, laminin and collagen deposition and the presence of blood vessels. Axonal reconnection via the scaffold was also confirmed by Fluro-gold retrograde tracing. Taken together, our work defines a novel route for building upon naturally occurring plant microarchitectures to support the repair of the spinal cord post-injury. Notably, these results were achieved without the use of growth factors, stem/progenitor cells, or any other interventions.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Biomaterials
78 papers in training set
Top 0.1%
22.5%
2
npj Regenerative Medicine
21 papers in training set
Top 0.1%
10.1%
3
Advanced Healthcare Materials
71 papers in training set
Top 0.3%
8.4%
4
Tissue Engineering Part A
15 papers in training set
Top 0.1%
4.3%
5
Acta Biomaterialia
85 papers in training set
Top 0.2%
4.3%
6
Advanced Functional Materials
41 papers in training set
Top 0.7%
3.7%
50% of probability mass above
7
Stem Cell Research & Therapy
30 papers in training set
Top 0.2%
3.6%
8
Advanced Science
249 papers in training set
Top 5%
3.6%
9
Bioengineering & Translational Medicine
21 papers in training set
Top 0.2%
2.6%
10
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 0.8%
2.6%
11
Bioactive Materials
18 papers in training set
Top 0.3%
2.4%
12
Journal of Biomedical Materials Research Part A
18 papers in training set
Top 0.1%
2.1%
13
Biomaterials Advances
20 papers in training set
Top 0.3%
1.9%
14
Scientific Reports
3102 papers in training set
Top 56%
1.8%
15
Biofabrication
32 papers in training set
Top 0.4%
1.8%
16
Advanced Materials
53 papers in training set
Top 1%
1.7%
17
Science Advances
1098 papers in training set
Top 23%
1.2%
18
ACS Biomaterials Science & Engineering
37 papers in training set
Top 0.7%
1.2%
19
Molecular Therapy
71 papers in training set
Top 2%
0.9%
20
Advanced Materials Interfaces
10 papers in training set
Top 0.2%
0.9%
21
PLOS ONE
4510 papers in training set
Top 64%
0.9%
22
Biomaterials Science
21 papers in training set
Top 0.5%
0.7%
23
Nature Communications
4913 papers in training set
Top 64%
0.7%
24
eLife
5422 papers in training set
Top 59%
0.7%
25
Cell Reports Physical Science
18 papers in training set
Top 1%
0.6%